CURLF - Curaleaf Holdings, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.08
|
Rev Est: $328.6M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.02
DETAILS
HIGH:
$23.87
LOW:
$6.25
MEDIAN:
$11.75
CONSENSUS:
$13.02
UPSIDE:
431.43%
Market Cap:
1.88B
Volume:
224,296
Avg Volume:
1,044,161
52 Week Range:
0.675-5.05
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
1.44
Last Dividend:
$N/A
Exchange:
OTC
Country:
US
Employees:
5,519
IPO Date:
2018-10-29
EPS (TTM):
-0.29
P/E Ratio:
-5.10
Revenue (TTM):
1.28B
Total Assets:
2.95B
Total Debt:
1.06B
Cash & Equiv:
107.16M
Rev Growth (5Y):
41.4%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-0.6%
Debt/Equity:
1.23
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.06 | $-0.07 | +14.3% | $320.2M | $328.3M | -2.4% |
| 2025-08-06 | $-0.06 | $-0.07 | +14.3% | $319.7M | $313.9M | +1.8% |
| 2025-05-08 | $-0.07 | $-0.07 | 0.0% | $310.0M | $311.3M | -0.4% |
| 2025-03-03 | $0.02 | $-0.06 | +133.3% | $331.1M | $332.2M | -0.4% |
| 2024-11-06 | $-0.07 | $-0.06 | -16.7% | $330.5M | $331.6M | -0.3% |
| 2024-08-07 | $-0.06 | $-0.05 | -20.0% | $342.2M | $344.9M | -0.8% |
| 2024-05-09 | $-0.07 | $-0.06 | -16.7% | $337.4M | $339.7M | -0.7% |
| 2024-03-06 | $-0.09 | $-0.06 | -50.0% | $354.8M | $337.7M | +5.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.28B | 1.37B | 1.22B | 1.19B | 659.74M | 226.16M | 73.13M | 20.01M | 0 | 0 | 0 |
| Net Income | (226.73M) | (286.35M) | (355.43M) | (204.13M) | (60.18M) | (68.81M) | (53.59M) | (2.92M) | (118,450) | (160,619) | (46,120) |
| EPS | -0.29 | -0.40 | -0.53 | -0.16 | -0.11 | -0.15 | -0.16 | -0.02 | -0.10 | -0.20 | -0.06 |
| Total Assets | 2.95B | 3.08B | 3.41B | 3.10B | 2.37B | 736.93M | 569.84M | 151.60M | 47,792 | 151,544 | 90,856 |
| Total Debt | 1.06B | 1.09B | 1.15B | 809.04M | 577.71M | 198.11M | 84.30M | 10.19M | 0 | 0 | 0 |
| Cash & Equivalents | 107.16M | 91.35M | 163.10M | 298.92M | 73.54M | 42.31M | 266.62M | 20.98M | 22,234 | 125,459 | 54,234 |
| Operating Cash Flow | 162.57M | 75.26M | 46.40M | (33.96M) | 12.36M | (38.32M) | (33.10M) | (7.71M) | (106,885) | (153,878) | (24,837) |
| Free Cash Flow | 64.42M | 5.05M | (91.96M) | (205.92M) | (113.92M) | (120.40M) | (78.96M) | (18.45M) | (107,475) | (162,537) | (34,184) |
| FCF per Share | 0.09 | 0.01 | -0.13 | -0.29 | -0.20 | -0.26 | -0.20 | -0.06 | -0.09 | -0.20 | -0.05 |
| Book Value | 860.70M | 1.05B | 1.28B | 1.54B | 1.38B | 408.76M | 440.77M | 105.39M | 36,260 | 142,880 | 81,658 |
| Cash & ST Investments | 107.16M | 91.35M | 163.10M | 298.92M | 73.54M | 42.31M | 266.62M | 20.98M | 22,234 | 125,459 | 54,234 |
| ROC Equity | -0.26 | -0.27 | -0.28 | -0.13 | -0.04 | -0.17 | -0.12 | -0.03 | -3.27 | -1.12 | -0.56 |